Clinical supply planning starts with assumptions, not sales history. See how enrollment, SKUs, approvals, shelf life, yield, inventory, and CDMOs shape the plan.
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- The Silent Stockout: No One Owns The Data That Would Have Caught It
- Token Costs Will Decide Clinical Supply AI
- What Is "Demand" When There Are No Sales?
- The Reliance Trap: When Regulatory Strategy Becomes A Clinical Supply Problem
- Clinical Trial Supply Chains Are Entering The Era Of Predictive Risk Management
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- CSM Feasibility Begins With Research Strategy And Study Design
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Building Clinical Supply Agility In A Changing Trial Landscape
Rising trial complexity demands agile supply built on integrated operations, solid planning, and fast issue resolution. Lean teams gain from partners providing flexibility, control, and global reach.
-
The Tale Of Two Clinical Supply Chains: The Risks Of Fragmented Systems
Here we examine two contrasting approaches to showcase how a centralized inventory management system is an effective tool for supporting a robust supply chain.
-
Prefillable Syringe Plungers: A Solution For Low Temperature Storage
Review a study with 1 mL long glass and polymer-based syringes and with 2.25 mL glass syringes. Explore the impacts on plunger movement, container closure integrity, and break loose and extrusion force.
-
Rare Diseases And The Integrated CDMO Support System
Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.
-
Key Considerations For Emerging Companies When Selecting Packaging Components
Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.
-
Key Considerations For Selecting Flexible Fillers
Flexible fillers are beneficial to drug developers looking for lifecycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.
-
How A Biotech Startup Transformed Its Clinical Trial Supply Management
Don’t let your trial get lost in the shuffle of legacy vendors. See how a high-touch, consultative approach can protect your study’s future.
-
When Every Hour Counts: Emergency Transfer Protects Critical Biomedical Materials
Rapid deployment of specialized cold chain logistics and cryogenic assets ensures strict temperature compliance, protecting critical research continuity and preventing catastrophic material loss.
-
Building A Flexible, Challenge Resistant, Patient-Centric Clinical Supply Chain
Flexible solutions, like demand-led supply and direct-to-patient distribution, are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies.
-
Overcoming Inventory Challenges For A Complex, Global Study
Explore how the optimization of Interactive Response Technologies (IRT) settings relieved the burden of managing global supply needs for a CRO customer and clinical sponsor.
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
- Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.